'We're not trying to be Silicon Valley': Inside Station F, where Paris is incubating the next tech and AI juggernauts
Paris's Station F, a converted train station, is a prolific incubator for tech startups.
The incubator has doubled down on the AI boom and is getting more interest from US startups.
Business Insider visited the vibrant space to see how it's driving France's tech boom.
In Paris's balmy thirteenth district, an airy rail depot that's been converted into a startup incubator is now the epicenter of France's tech boom.
Walking through Station F, it's hard not to see how the 366,000-square-foot space has been influenced by Silicon Valley, with its amenities like a huge cafeteria and an under-construction yoga studio that are reminiscent of Big Tech campuses.
But Station F's director, Roxanne Varza, told Business Insider that it is not trying to become an American incubator. "We've been inspired by a lot of players, and we look up to Y Combinator. But we're not trying to be Silicon Valley," she said.
Now, politics is helping drive international founders here, including Americans, Varza told BI during a recent visit.
The election of Donald Trump and Brexit were among the biggest catalysts driving international founders to Station F, Varza told BI. After France, the US and UK are the most represented nationalities on campus, which houses entrepreneurs from 70 nationalities, Varza said.
At times of political volatility, the campus has been a magnet for founders seeking a global outlook and a supply of talent. Trump 2.0 — and its aftermath, including the announcement of Stargate and DeepSeek — galvanized European founders to step up, Varza said.
The US tech ecosystem secured $209 billion in VC funding in 2024, about 17 times more than France. But Paris is catching up to its global counterparts. In 2025, technology research platform Dealroom billed the city as Europe's new tech champion, overtaking London's mantle. From 2017 to 2024, the combined enterprise value of startups based in Paris increased 5.3 times, more than any other European tech hub.
Climate tech founders in particular have been coming from the US to Station F amid the Trump administration cutting incentives for green industries in the US, Varza said.
Materials discovery startup Entalpic, which launched in 2024, has had a flurry of US applicants vying for jobs at the company since the start of the year, its cofounder, Alexandre Duval, told BI. Duval had planned to move his startup out of Station F once it reached 20 employees, but decided to stay. "We have so many resources here: meeting rooms, onboarding, events, opportunities to meet people. It's good," he said.
Station F, the handiwork of French billionaire Xavier Neil, launched in 2017 to drive entrepreneurship in France's tech ecosystem.
The Station F team accepts around 40 startups every month. In addition to access to the incubator's coworking space, startups get resources and mentorship, including from government officials and Big Tech companies, such as Meta and Microsoft, that have offices at Station F.
Station F's flagship Founders Program offers founders workshops and masterclasses. In return, the incubator takes 1% equity — a more favourable figure than the 6% taken by Y Combinator. The incubator also aims to write checks of $50,000 to $100,000 to around 20 upstarts each year.
The result is a hubbub of innovators collaborating and ideating all days of the week — a far cry from how some corners of LinkedIn see Europe's tech ecosystem as the butt of the joke for its supposed lax work culture compared to Silicon Valley.
Station F has welcomed everyone from the prime minister of Ethiopia to the CEO of Cisco — and the morning I arrive, the CEO of GitHub is scheduled to speak for a Q&A as part of VivaTech, France's flagship tech event that attracted speakers such as Nvidia's Jensen Huang. "The No. 1 reason people come here is for the access to people," Varza added.
Like many of its international counterparts, Station F has doubled down on the AI boom.
Government initiatives under France's president Emmanuel Macron, as well as generous financing from the country's national bank, Bpifrance, have galvanized the region's AI startups.
In 2023, French AI startups raised $1.9 billion, per PitchBook data. In 2024, this figure rose by more than 50% to $2.98 billion. Notable rounds included Mistral's $600 million raise in June 2024 and H's mammoth $220 million seed round in May 2024.
So far this year, French AI companies have raised $1.7 billion in VC funding, and Macron announced in February an additional $112 billion in private sector funding earmarked for the country's AI ecosystem.
High-profile investors such as Andreessen Horowitz, General Catalyst, and Lightspeed Ventures have flocked to back prolific AI startups founded in France, such as Mistral, Dust, and Poolside.
Open-source AI company Hugging Face, now valued at $4.5 billion, was once incubated in Station F. Now, Varza said, around 40% of France's AI startups are spinning out of the program.
In 2024, 34 out of 40 of the top startups touted by Station F — its "Future 40" — were AI companies.
"Station F is one of the biggest AI communities in Europe," Varza says. "It's also an entry point for so many tier one investors coming to Europe — and we're seeing more Series A and B rounds too."
Beyond helping AI startups raise financing, Station F also participates in regulatory debates about France's tech ecosystem, Varza added. "Right now, the government is talking about how we can fiscally incentivise AI companies and push creation. We're in those discussions very actively."
I was keen to speak to AI and climate founders, and within two minutes, Varza had grabbed two people for me to speak to.
It was a reflection of how Station F operates: touting collaboration over competition. Despite the vast space, I saw founders from different startups huddled together in various pockets of the station, congregating for in-house events such as Q&As, as well as the bustling restaurant space.
"We saw incredible things happen when people were working in close spaces," Varza said. "You see everything from VR and AI companies collaborating — and even companies winding down and neighbouring teams acquiring them."
She recalled how one startup in the incubator wanted to pivot and copied a neighbouring company's idea. "It's our only copycat story, but they both ended up being pretty successful," she added.
Station F is working on initiatives with Japan and the Gulf region, Varza said — but what excites her most is the opportunity to take what they've built in Paris and "build those bridges" internationally across Europe.
Read the original article on Business Insider
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Gizmodo
18 minutes ago
- Gizmodo
Good News! Jeff Bezos Is Married
Jeff Bezos is officially off the market. The Amazon founder married his fiancée, former TV anchor Lauren Sánchez, in a lavish ceremony on Friday, June 27, on the private island of San Giorgio Maggiore in Venice, Italy, capping a multi-day spectacle of wealth, power, and controversy. Sánchez shared a radiant Instagram post of herself in a flowing white dress alongside Bezos, suited up in a tuxedo. The wedding marked the culmination of a multi-day spectacle that drew 200 celebrity guests, dozens of private jets, luxury yachts, and plenty of social media attention. Among the A-list attendees: Oprah Winfrey, Kris Jenner, Kim and Khloé Kardashian, Barbra Streisand, George and Amal Clooney, and Leonardo DiCaprio, who, notably, once became the subject of an internet meme after an awkward red-carpet encounter with Sánchez. View this post on InstagramBut on the streets of the historic city, a different story was unfolding. As Gizmodo previously reported, the announcement of the wedding's location sparked immediate and organized protests from locals. Under the banner of 'No Space For Bezos,' a dozen Venetian organizations, from housing advocates to anti-cruise ship campaigners, denounced what they see as the exploitation of their city. Protesters argue that the wedding, with an estimated price tag north of $50 million, exemplifies the forces that are making Venice uninhabitable for its own residents: rampant overtourism, soaring housing costs, and the constant threat of climate-induced flooding. They staged small-scale demonstrations throughout the week, unfurling anti-Bezos banners at iconic sites. The pressure ultimately forced the couple to move their main reception party to the Arsenale, a medieval complex deemed more secure and less susceptible to protest flotillas. The city's governor, Luca Zaia, defended the wedding as an economic boon, but critics on the ground pointed to Amazon's controversial labor practices and ongoing tax disputes as reasons for their concern. Bezos' wedding is a raw display of power. In the 21st century, tech billionaires are the new royalty, and their weddings have become de facto coronations. They are meticulously crafted PR events designed to project an image of benevolent, cultured, and almost feudal power. The pre-wedding invitation, as previously discussed, was a perfect example of this. It kindly requested 'no gifts' and instead highlighted the couple's donations to three local environmental research groups. It's a classic move: wrap an event of staggering carbon-footprint excess in the soft packaging of eco-philanthropy. The message is clear: we can afford to buy an entire city for a weekend, and we can also afford to save it. Ultimately, the Bezos-Sánchez wedding serves as a powerful symbol of our era, where the logistical power of a tech empire can requisition a historic city, where the line between celebrity and tech titan has completely blurred, and where even the most extravagant displays of wealth come with a carefully worded press release about giving back.
Yahoo
29 minutes ago
- Yahoo
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
The healthcare sector offers an abundance of high-growth investment opportunities. Companies leveraging artificial intelligence and genomic medicine are delivering innovative therapies with significant potential. Small-cap and under-the-radar stocks with strong growth possibilities merit closer investor attention. 10 stocks we like better than TransMedics Group › There's a strong case that healthcare is the most important sector in the stock market. These companies deliver innovative therapies and medical technologies that are often life-saving. Investors stand to benefit as healthcare leaders and emerging players address the needs of an aging global population and the rising prevalence of chronic diseases. Here are 10 under-the-radar healthcare stocks that could be great buys for your portfolio. Certara (NASDAQ: CERT) is poised to capitalize on the transformation in medicine driven by artificial intelligence (AI), providing bio-simulation software and services that accelerate drug development. The company plays a crucial role in the pharmaceutical industry. Over 90% of all novel drugs approved by the Food and Drug Administration (FDA) since 2014 have leveraged its technology. Its AI-driven solutions enhance research and development (R&D), enabling faster and more precise drug development. Certara deserves a closer look by investors seeking to tap into the AI-driven healthcare transformation. Beam Therapeutics (NASDAQ: BEAM) is a clinical-stage biotech pioneering precision-based gene editing therapies for genetic diseases, including sickle cell disease. Its innovative technology enables precise single-nucleotide DNA changes, potentially offering a safer alternative to traditional CRISPR genetic engineering. Beam has reported early success in gene correction, with its lead candidate, BEAM-101, in phase 1/2 trials for sickle cell disease. While the company still has a lot to prove, its differentiated approach and clinical progress position it for remarkable growth in the long term. Inspire Medical Systems (NYSE: INSP) develops implantable neurostimulation devices for obstructive sleep apnea, offering its FDA-approved Inspire therapy as a noninvasive alternative to CPAP machines. In its first quarter (the period ended March 31), revenue surged 23% year over year to $201 million, driven by growing U.S. adoption and new international approvals. With increasing demand for sleep apnea treatment, Inspire has a significant opportunity to capture market share. Insulet (NASDAQ: PODD) specializes in tubeless insulin pump technology. Its Omnipod system simplifies diabetes management for Type 1 and insulin-dependent Type 2 patients globally, offering convenience and improved outcomes. With a 2025 revenue growth target of 19% to 22%, the company is poised for continued expansion, particularly in underpenetrated international markets. Insulet's strong growth trajectory positions it to reward shareholders further. Krystal Biotech (NASDAQ: KRYS) focuses on rare skin diseases. Its FDA-approved gene therapy, Vyjuvek, for dystrophic epidermolysis bullosa (fragile skin that blisters easily) is expected to approach $400 million in revenue this year, solidifying its position as a best-in-class treatment. Vyjuvek's success validates Krystal's R&D, bolstering confidence in its pipeline and unlocking added market potential. LifeMD (NASDAQ: LFMD) operates a telehealth platform providing specialized virtual care in weight loss, men's health, and dermatology. A partnership with Novo Nordisk to offer Wegovy, a leading GLP-1 treatment, has driven impressive growth, with first-quarter revenue surging 49% year over year for the period ended March 31. LifeMD could expand its growing user base into a comprehensive health management ecosystem to fuel growth and solidify its telehealth leadership. Option Care Health (NASDAQ: OPCH) is the leading U.S. provider of home and alternative-site infusion services, delivering crucial therapies for chronic and acute conditions like cancer, immune deficiencies, and infections. As the healthcare industry shifts toward more personalized and cost-effective care, Option Care Health is in position to capitalize on the strong demand, with its extensive network and high-quality services. Tempus AI (NASDAQ: TEM) harnesses artificial intelligence to advance precision medicine, using its collection of clinical and molecular data from more than 40 million patients to power diagnostics in oncology, cardiology, and beyond. The company projects its revenue to climb by more than 80% this year, to about $1.3 billion. Tempus AI's scalable platform and extensive data ecosystem present substantial opportunities for expansion and impact in personalized healthcare. TransMedics Group (NASDAQ: TMDX) has revolutionized organ transplantation with its Organ Care System (OCS), the only FDA-approved device for heart, lung, and liver transplants that extends organ preservation time. The company's projected revenue growth of 30% this year underscores the strong momentum in a global expansion opportunity. Veeva Systems (NYSE: VEEV) offers cloud-based software that streamlines clinical, regulatory, and commercial processes for life sciences companies. Serving over 1,000 customers, including major pharmaceutical companies and emerging biotechs, Veeva's platform is well positioned to capitalize on the industry's increasing reliance on digital solutions for innovation and compliance. Before you buy stock in TransMedics Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and TransMedics Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 177% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Dan Victor has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Beam Therapeutics, Inspire Medical Systems, TransMedics Group, and Veeva Systems. The Motley Fool recommends Insulet, Krystal Biotech, and Novo Nordisk. The Motley Fool has a disclosure policy. 10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential was originally published by The Motley Fool
Yahoo
38 minutes ago
- Yahoo
Corus Entertainment Third Quarter 2025 Earnings: CA$0.04 loss per share (vs CA$3.86 loss in 3Q 2024)
Revenue: CA$297.8m (down 10% from 3Q 2024). Net loss: CA$7.34m (loss narrowed by 99% from 3Q 2024). CA$0.04 loss per share (improved from CA$3.86 loss in 3Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Looking ahead, revenue is expected to decline by 7.2% p.a. on average during the next 3 years, while revenues in the Media industry in North America are expected to grow by 2.8%. Performance of the market in Canada. The company's share price is broadly unchanged from a week ago. We don't want to rain on the parade too much, but we did also find 3 warning signs for Corus Entertainment (2 are significant!) that you need to be mindful of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio